1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. GLOBAL ARTIFICIAL ORGAN MARKET BY PRODUCT TYPE
4.1. Introduction
4.2. Artificial Heart
4.3. Artificial Kidney
4.4. Artificial Lungs
4.5. Artificial Liver
4.6. Artificial Pancreas
4.7. Cochlear Implants
4.8. Other Types
5. GLOBAL ARTIFICIAL ORGAN MARKET BY MATERIAL
5.1. Introduction
5.2. Metal
5.3. Polymer
5.4. Others
6. GLOBAL ARTIFICIAL ORGAN MARKET BY APPLICATION
6.1. Introduction
6.2. Permanent Organ Replacement
6.3. Temporary Organ Replacement
7. GLOBAL ARTIFICIAL ORGAN MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Research Institutes
7.4. Others
8. GLOBAL ARTIFICIAL ORGAN MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. France
8.4.3. Germany
8.4.4. Spain
8.4.5. Italy
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Baxter International Inc.
10.2. Boston Scientific Corporation
10.3. Asahi Kasei Medical Co., Ltd.
10.4. Medtronic PLC
10.5. Carmat SA
10.6. Terumo Corporation
10.7. Miromatrix Medical Inc. (United Therapeutics Corporation)
10.8. BiVACOR Inc.
10.9. Cochlear Ltd.
10.10. Edwards Lifesciences Corporation
10.11. Zimmer Biomet Holding Inc.